E-DRUG: GDP per person living with HIV/AIDS

E-drug: GDP per person living with HIV/AIDS
----------------------------------------------------------------
[copied from PHARM-POLICY]

There are a couple of interesting contrasts regarding the
country GDP per person living with HIV/AIDS

http://www.cptech.org/ip/health/sa/aidsgdp1.html

Using 1997 data:

Group 1

Japan $ 616,210,735
UK $ 51,459,520
France $ 12,659,100
USA $ 9,553,702

Group 2

Thailand $ 197,319
India $ 93,065
South Africa $ 44,515
Botswana $ 26,684
Uganda $ 7,077
Zambia $ 5,019
Mozambique $ 2,294

Question:

Which of these countries support compulsory
licensing of HIV/AIDS drugs and which oppose
compulsory licensing of HIV/AIDS drugs?

Answer:

Group one opposes, and group two supports.

Jamie
--
James Love, Director, Consumer Project on Technology
I can be reached at love@cptech.org, by telephone 202.387.8030,
by fax at 202.234.5176. CPT web page is http://www.cptech.org
--
Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'.
Mail administrative requests to `majordomo@usa.healthnet.org'.
For additional assistance, send mail to: `owner-e-drug@usa.healthnet.org'.